Status:

COMPLETED

The China Valvular Heart Disease Study

Lead Sponsor:

China National Center for Cardiovascular Diseases

Collaborating Sponsors:

Chinese Academy of Medical Sciences

Conditions:

Valvular Heart Disease

Eligibility:

All Genders

18+ years

Brief Summary

This is a observational、multicenter, prospective cohort study for adults with significant VHD. The purposes of this study were to evaluate the etiology、clinical characteristics、treatment modalities, a...

Eligibility Criteria

Inclusion

  • patients over 60 years old meet one of the following conditions.
  • moderate or above valvular heart disease as defined by echocardiography: (1)aortic stenosis, moderate or above, or valve area ≤1.5cm2, or maximal jet velocity ≥3.0m/sec, or mean pressure gradient ≥20mmHg, (2)aortic regurgitation, moderate or above, or jet width ≥25% of left ventricular outflow tract, or regurgitant volume ≥30ml/beat, or regurgitant fraction ≥30%, (3)mitral stenosis, moderate or above, or valve area ≤1.5cm2, (4)mitral regurgitation, moderate or above, or effective regurgitant orifice ≥0.2cm2, or regurgitant volume ≥30ml/beat, or regurgitant fraction ≥30%, (5)tricuspid stenosis, moderate or above, or valve area ≤1.0cm2, (6)tricuspid regurgitation, moderate or above, or central jet area ≥5.0cm2, (7)pulmonic stenosis, moderate or above, or maximal jet velocity \>4m/sec, (8)pulmonic regurgitation, moderate or above,
  • or patients who had undergone any operation on a cardiac valve (percutaneous balloon commissurotomy, valve repair, valve replacement, transcatheter aortic valve implantation),
  • or diagnosis of endocarditis as assessed by Duke criteria.

Exclusion

  • Patients cannot be followed up for any reasons. Patients have been enrolled in this study.

Key Trial Info

Start Date :

April 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2020

Estimated Enrollment :

13917 Patients enrolled

Trial Details

Trial ID

NCT03484806

Start Date

April 1 2018

End Date

October 1 2020

Last Update

April 13 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fuwai Hospital, National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences

Beijing, Beijing Municipality, China, 100037